IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 121 filers reported holding IMMUNOVANT INC in Q4 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $206,555 | -15.1% | 13,352 | -2.6% | 0.00% | – |
Q4 2022 | $243,246 | -88.8% | 13,704 | -94.5% | 0.00% | -100.0% |
Q3 2021 | $2,180,000 | -17.7% | 250,854 | +0.0% | 0.00% | -50.0% |
Q2 2021 | $2,650,000 | -33.7% | 250,742 | +0.6% | 0.00% | -33.3% |
Q1 2021 | $3,999,000 | – | 249,311 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpine Global Management, LLC | 3,007,000 | $25,620,000 | 3.77% |
Deep Track Capital, LP | 4,775,000 | $40,683,000 | 2.87% |
Octagon Capital Advisors LP | 572,862 | $4,881,000 | 0.95% |
Eventide Asset Management | 4,950,000 | $42,174,000 | 0.54% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,197,000 | 0.44% |
FRAZIER MANAGEMENT LLC | 585,759 | $4,991,000 | 0.38% |
MANGROVE PARTNERS IM, LLC | 688,000 | $5,862,000 | 0.35% |
BCK CAPITAL MANAGEMENT LP | 54,293 | $463,000 | 0.31% |
EcoR1 Capital, LLC | 1,140,819 | $9,720,000 | 0.31% |
MANGROVE PARTNERS IM, LLC | 570,400 | $4,860,000 | 0.29% |